To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06877533
Title A First-in-Human Open-label, Phase I/Ib Dose Escalation and Expansion Cohort Study of EOS006215 As Monotherapy and in Combination with Pembrolizumab or Other Anticancer Treatments in Participants with Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors iTeos Belgium SA
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | BEL

Facility Status City State Zip Country Details
Sarah Cannon Research Institute at HealthOne RECRUITING Denver Colorado 80218 United States Details
Florida Cancer Specialists (FSC SAC DDU) Sarasota RECRUITING Sarasota Florida 24232 United States Details
Beth Israel Deaconess Medical Center NOT_YET_RECRUITING Boston Massachusetts 02215 United States Details
SCRI Oncology Partners RECRUITING Nashville Tennessee 37203 United States Details
MD Anderson NOT_YET_RECRUITING Houston Texas 77030 United States Details
Institut Jules Bordet NOT_YET_RECRUITING Brussels 1070 Belgium Details
UZ Gent NOT_YET_RECRUITING Gent 9000 Belgium Details
UZ Leuven NOT_YET_RECRUITING Leuven 3000 Belgium Details
Cliniques Universitaires Saint-Luc NOT_YET_RECRUITING Woluwé-Saint-Lambert 1200 Belgium Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field